BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18724299)

  • 1. Treatment strategies for patients with severe aplastic anemia.
    Bacigalupo A
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S42-S44. PubMed ID: 18724299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation.
    Gillio AP; Boulad F; Small TN; Kernan NA; Reyes B; Childs BH; Brochstein JA; Laver J; Castro-Malaspina H; O'Reilly RJ
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):18-24. PubMed ID: 9209737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with marrow transplantation or immunosuppression of childhood acquired severe aplastic anemia: a report from the EBMT SAA Working Party.
    Locasciulli A; van't Veer L; Bacigalupo A; Hows J; Van Lint MT; Gluckman E; Nissen C; McCann S; Vossen J; Schrezenmeier A
    Bone Marrow Transplant; 1990 Sep; 6(3):211-7. PubMed ID: 2252962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unrelated donor marrow transplantation for severe aplastic anaemia.
    Howard MR
    Transfus Sci; 1991; 12(3):123-34. PubMed ID: 10149542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
    Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
    Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indications, problems and future perspectives of bone marrow transplantation in pediatrics].
    Slavc I
    Padiatr Padol; 1992; 27(6):167-75. PubMed ID: 1484709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved survival in severe acquired aplastic anemia of childhood.
    Fouladi M; Herman R; Rolland-Grinton M; Jones-Wallace D; Blanchette V; Calderwood S; Doyle J; Halperin D; Leaker M; Saunders EF; Zipursky A; Freedman MH
    Bone Marrow Transplant; 2000 Dec; 26(11):1149-56. PubMed ID: 11149724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the most effective treatment of children with severe aplastic anemia who lack a matched sibling donor?
    Johnson FL
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S39-44. PubMed ID: 8971407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive therapy: a potential alternative to bone marrow transplantation as initial therapy for acquired severe aplastic anemia in childhood?
    Lawlor ER; Anderson RA; Davis JH; Fryer CJ; Pritchard SL; Rogers PC; Wu JK; Schultz KR
    J Pediatr Hematol Oncol; 1997; 19(2):115-23. PubMed ID: 9149740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of aplastic anemia--aims and development of the SAA 94 pilot protocol].
    Führer M; Bender-Götze C; Ebell W; Friedrich W; Kohne E
    Klin Padiatr; 1994; 206(4):289-95. PubMed ID: 7967425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).
    Locasciulli A; Oneto R; Bacigalupo A; Socié G; Korthof E; Bekassy A; Schrezenmeier H; Passweg J; Führer M;
    Haematologica; 2007 Jan; 92(1):11-8. PubMed ID: 17229630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the North American Pediatric Aplastic Anemia Consortium and the Pediatric Transplantation and Cellular Therapy Consortium.
    Pulsipher MA; Lehmann LE; Bertuch AA; Sasa G; Olson T; Nakano T; Gilio A; Burroughs LM; Lipton JM; Huang JN; Dickerson K; Bertaina A; Zhuang C; Malsch M; Fleming M; Weller E; Shimamura A; Williams DA
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28444. PubMed ID: 32776425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin.
    Inagaki J; Nagatoshi Y; Kawano Y; Saito Y; Takahashi D; Nagayama J; Shinkoda Y; Hirata H; Okamura J
    Pediatr Transplant; 2007 Mar; 11(2):180-6. PubMed ID: 17300498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective survey on the prevalence and outcome of prior autoimmune diseases in patients with aplastic anemia reported to the registry of the European group for blood and marrow transplantation.
    Cesaro S; Marsh J; Tridello G; Rovò A; Maury S; Montante B; Masszi T; Van Lint MT; Afanasyev B; Iriondo Atienza A; Bierings M; Carbone C; Doubek M; Lanino E; Sarhan M; Risitano A; Steinerova K; Wahlin A; Pegoraro A; Passweg J
    Acta Haematol; 2010; 124(1):19-22. PubMed ID: 20606411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus as an alternative to cyclosporine in the maintenance phase of immunosuppressive therapy for severe aplastic anemia in children.
    Alsultan A; Goldenberg NA; Kaiser N; Graham DK; Hays T
    Pediatr Blood Cancer; 2009 May; 52(5):626-30. PubMed ID: 19148946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aplastic anemia--contemporary procedures and therapeutic perspectives].
    Zawirska D; Skotnicki AB
    Przegl Lek; 1999; 56(7-8):506-14. PubMed ID: 10575919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic bone marrow transplantation (BMT) for acquired severe aplastic anaemia (SAA) in children.
    Locasciulli A; Vossen J; Bacigalupo A; Hows J; VanLint MT; Gluckman E; Nissen C; McCann S; de Planque M; van'tVeer L
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():123-5. PubMed ID: 2697423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of acquired aplastic anaemia.
    Marsh JC
    Blood Rev; 2005 May; 19(3):143-51. PubMed ID: 15748962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of patients activating an unrelated donor search for severe acquired aplastic anemia.
    Maury S; Balère-Appert ML; Pollichieni S; Oneto R; Yakoub-Agha I; Locatelli F; Dalle JH; Lanino E; Fischer A; Pession A; Huynh A; Barberi W; Mohty M; Risitano A; Milpied N; Socié G; Bacigalupo A; Marsh J; Passweg JR;
    Am J Hematol; 2013 Oct; 88(10):868-73. PubMed ID: 23804195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of children with aplastic anemia.
    Kurre P; Johnson FL; Deeg HJ
    Pediatr Blood Cancer; 2005 Nov; 45(6):770-80. PubMed ID: 15706582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.